The financial results were actually positive, at the higher end of analysts' forecasts, but profit guidance for 2025 ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...

JERUSALEM, Jan 29 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab reported a slightly larger than expected rise in fourth-quarter profit, helped by double-digit sales gains in ...